Some brands may be represented differently in select markets
Your Rapid Respiratory Testing Solutions
Respiratory infection symptoms can be misleading, and can result in misdiagnosis, unnecessary tests, overuse of antimicrobials, and the continued spread of an infection throughout the community. When you need to diagnose a respiratory infection, you shouldn’t have to choose between speed and accuracy. With the help of rapid respiratory testing solutions from Abbott, practitioners can quickly and accurately determine whether respiratory infections are self-limiting or require therapy.
The sooner you know results, the more effectively you can manage respiratory care.
Respiratory infections pose a two-pronged threat to human health. Failure to treat patients quickly and appropriately could result in outbreaks and epidemics, while overuse of antibiotics can spur the emergence of antimicrobial-resistant infections.1, 2 Abbott's respiratory products can help practitioners define appropriate treatment strategies fast.
ID NOW Influenza A&B 2 is the world’s first-ever CLIA-waived molecular, point-of-care test.3
Our Respiratory Testing Products
Rely on a market leader in rapid respiratory diagnostics.
Abbott offers a range of rapid respiratory point-of-care testing options. Our high-performance solutions help clinicians identify pathogens immediately and accurately, so they can determine appropriate treatment strategies sooner.